retatrutide peptide clinical trials Today, we shared new data from two Phase 3 of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v retatrutide clinical trials efficacy (RETA)

Not everyone gets approved

Molnupiravir and risk of post-acute sequelae of Covid-19: cohort study

Any products and informational content displayed on this page are not intended to diagnose, treat, cure, or prevent any disease.

T., Aoutla, S., Jyothi, N., Mohamed Kalifa, M

Congress Introduces SAFE Drugs Act of 2025, Expanding FDA Oversight of Compounded GLP-1 Drugs and Telehealth Providers Legal Alerts 2.12.26 Takeaways The bill would limit 503A pharmacies from compounding large volumes of drugs that are essentially copies of commercially available FDA-approved products

They also found large quantities of sophisticated packaging and manufacturing equipment, along with about 20,000 in cash suspected to be linked to medicines trafficking